Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Bedell

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Nucleic Acids Research|August 2, 2012
2'-Deoxyriboguanylurea, the primary breakdown product of 5-aza-2'-deoxyribocytidine, is a mutagen, an epimutagen, an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sitesKatarzyna Lamparska, Jarrod Clark, Gail Babilonia, et al.
Cancer Genetics and Cytogenetics|March 31, 2005
Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridizationMarilyn L Slovak, Victoria Bedell, Kristen Pagel, et al.
Genes, Chromosomes & Cancer|March 29, 2002
21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshopMarilyn L Slovak, Victoria Bedell, Leslie Popplewell, et al.
The Journal of Molecular Diagnostics : JMD|November 3, 2007
Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sectionsVictoria Bedell, Stephen J Forman, Karl Gaal, et al.
American Journal of Clinical Pathology|February 28, 2002
Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocationsDaniel A Arber, Marilyn L Slovak, Leslie Popplewell, et al.
Human Pathology|September 25, 2003
Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasiaDaniel A Arber, Karen L Chang, Mark H Lyda, et al.
Obstetrics and Gynecology|September 9, 2016
Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysisShayna N Conner, Victoria Bedell, Kim Lipsey, et al.
Cancer Genetics and Cytogenetics|April 25, 2006
Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomasWarren A Chow, Victoria Bedell, Popsie Gaytan, et al.
Molecular Cancer Therapeutics|May 18, 2005
Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myelomaLijun Zhu, George Somlo, Bingsen Zhou, et al.
Leukemia Research|August 1, 2006
Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic cloneVinod Pullarkat, Victoria Bedell, Young Kim, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Nucleic Acids Research|August 2, 2012
2'-Deoxyriboguanylurea, the primary breakdown product of 5-aza-2'-deoxyribocytidine, is a mutagen, an epimutagen, an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sitesKatarzyna Lamparska, Jarrod Clark, Gail Babilonia, et al.
Cancer Genetics and Cytogenetics|March 31, 2005
Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridizationMarilyn L Slovak, Victoria Bedell, Kristen Pagel, et al.
Genes, Chromosomes & Cancer|March 29, 2002
21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshopMarilyn L Slovak, Victoria Bedell, Leslie Popplewell, et al.
The Journal of Molecular Diagnostics : JMD|November 3, 2007
Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sectionsVictoria Bedell, Stephen J Forman, Karl Gaal, et al.
American Journal of Clinical Pathology|February 28, 2002
Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocationsDaniel A Arber, Marilyn L Slovak, Leslie Popplewell, et al.
Human Pathology|September 25, 2003
Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasiaDaniel A Arber, Karen L Chang, Mark H Lyda, et al.
Obstetrics and Gynecology|September 9, 2016
Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysisShayna N Conner, Victoria Bedell, Kim Lipsey, et al.
Cancer Genetics and Cytogenetics|April 25, 2006
Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomasWarren A Chow, Victoria Bedell, Popsie Gaytan, et al.
Molecular Cancer Therapeutics|May 18, 2005
Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myelomaLijun Zhu, George Somlo, Bingsen Zhou, et al.
Leukemia Research|August 1, 2006
Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic cloneVinod Pullarkat, Victoria Bedell, Young Kim, et al.
Pageof 4